Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine|November 18, 2000
Prediction of functional outcome by quantification of sestamibi and BMIPP after acute myocardial infarctionA S Hambÿe, A Vervaet, A Dobbeleir, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2009
Crystalluric and tubular epithelial parameters during the onset of intratubular nephrocalcinosis: illustration of the 'fixed particle' theory in vivoBenjamin A Vervaet, Patrick C D'Haese, Marc E De Broe, et al.
Brain and Language|December 9, 1998
Normative data for the Boston naming test in native Dutch-speaking Belgian elderlyP Mariën, E Mampaey, A Vervaet, et al.
International Journal of Molecular Sciences|May 27, 2023
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic EffectRaphaëlle Corremans, Benjamin A Vervaet, Geert Dams, et al.
Nephron|July 28, 2017
Untargeted DNA-Demethylation Therapy Neither Prevents Nor Attenuates Ischemia-Reperfusion-Induced Renal FibrosisBenjamin A Vervaet, Lies Moonen, Lode Godderis, et al.
Urological Research|August 4, 2010
The tubular epithelium in the initiation and course of intratubular nephrocalcinosisBenjamin A Vervaet, Anja Verhulst, Marc E De Broe, et al.
The Journal of Urology|December 12, 2012
Lanthanum carbonate inhibits intestinal oxalate absorption and prevents nephrocalcinosis after oxalate loading in ratsStef Robijn, Benjamin A Vervaet, Bernd Hoppe, et al.
Kidney International|August 26, 2011
Hyperoxaluria: a gut-kidney axis?Stef Robijn, Bernd Hoppe, Benjamin A Vervaet, et al.
International Journal of Molecular Sciences|December 26, 2018
Metformin: A Candidate Drug for Renal DiseasesRaphaëlle Corremans, Benjamin A Vervaet, Patrick C D'Haese, et al.
Nuclear Medicine Communications|July 1, 1996
240 degrees: why not?A S Hambye, A Dobbeleir, E Stulens, et al.
Pageof 5